Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.
What the Market Looks Like?
The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. In 2019, North America accounted for the largest market share, followed by Europe.
Maternal age refers to the age of women at the time of delivery. Advancing maternal age can result in a number of health complications, such as decreased fertility, high blood pressure, and an increase in the risk of miscarriage, stillbirths, and maternal death. Moreover, advancing maternal age can increase the risk of genetic disorders in babies as a result of the improper chromosomal division.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690
What Drives the Market?
The growth of the Non Invasive Prenatal Testing (NIPT) Market is primarily influenced by the following factors:
- High Risk of Chromosomal Abnormalities With Increasing Maternal Age
- Growing Preference for Noninvasive Techniques Over Invasive Methods
- Improving Reimbursement Scenario for NIPT
- Programs Focusing on Increasing the Awareness of NIPT
By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.
Read more about Non Invasive Prenatal Testing (NIPT) Market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690